Jane Street Group LLC lessened its stake in shares of National Research Co. (NASDAQ:NRC – Free Report) by 72.9% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 9,765 shares of the company’s stock after selling 26,293 shares during the quarter. Jane Street Group LLC’s holdings in National Research were worth $223,000 as of its most recent filing with the SEC.
Several other hedge funds have also added to or reduced their stakes in the stock. Quarry LP bought a new position in shares of National Research during the 2nd quarter worth $54,000. Benjamin F. Edwards & Company Inc. lifted its holdings in National Research by 145.6% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 2,783 shares of the company’s stock valued at $64,000 after purchasing an additional 1,650 shares during the last quarter. FMR LLC lifted its holdings in National Research by 397.3% during the third quarter. FMR LLC now owns 2,944 shares of the company’s stock valued at $67,000 after purchasing an additional 2,352 shares during the last quarter. Gladius Capital Management LP boosted its position in National Research by 164.5% during the third quarter. Gladius Capital Management LP now owns 3,068 shares of the company’s stock worth $70,000 after purchasing an additional 1,908 shares during the period. Finally, Point72 Asset Management L.P. purchased a new position in shares of National Research in the third quarter worth about $88,000. Institutional investors own 47.26% of the company’s stock.
National Research Stock Performance
Shares of NRC stock opened at $16.79 on Monday. The firm’s 50 day moving average is $18.62 and its 200 day moving average is $20.62. The stock has a market capitalization of $394.16 million, a P/E ratio of 14.86 and a beta of 0.53. National Research Co. has a 12 month low of $16.64 and a 12 month high of $42.00. The company has a current ratio of 0.47, a quick ratio of 0.47 and a debt-to-equity ratio of 1.30.
National Research Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, January 10th. Shareholders of record on Friday, December 27th were paid a $0.12 dividend. The ex-dividend date was Friday, December 27th. This represents a $0.48 annualized dividend and a yield of 2.86%. National Research’s dividend payout ratio is currently 42.48%.
National Research Company Profile
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
See Also
- Five stocks we like better than National Research
- How to Use the MarketBeat Stock Screener
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- Following Congress Stock Trades
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Want to see what other hedge funds are holding NRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Research Co. (NASDAQ:NRC – Free Report).
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.